In addition, we further noticed that the downregulated expression of lncRNA SOX2-OT significantly reduced the ROS levels and enhanced the SOD activity in MPP+-treated SH-SY5Y cells in the in vitro PD cell model. The gene discussed is SOD1; the disease is Parkinson disease.